C2ORF76 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.700600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.987400E-01
Normal-vs-Stage2
5.755400E-01
Normal-vs-Stage3
9.889200E-01
Normal-vs-Stage4
6.385400E-01
Stage1-vs-Stage2
5.706200E-01
Stage1-vs-Stage3
8.844600E-01
Stage1-vs-Stage4
5.283800E-01
Stage2-vs-Stage3
5.078800E-01
Stage2-vs-Stage4
1.883620E-01
Stage3-vs-Stage4
6.565000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.821800E-01
Normal-vs-AfricanAmerican
7.429800E-01
Normal-vs-Asian
2.593400E-01
Caucasian-vs-AfricanAmerican
4.288400E-01
Caucasian-vs-Asian
1.058750E-01
AfricanAmerican-vs-Asian
1.083560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.987400E-01
Normal-vs-Female
6.493600E-01
Male-vs-Female
9.849600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.736580E-01
Normal-vs-Age(41-60Yrs)
9.360200E-01
Normal-vs-Age(61-80Yrs)
5.898800E-01
Normal-vs-Age(81-100Yrs)
2.913200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.626800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.138400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.855000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.298770E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.090050E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.086600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.443600E-01
Normal-vs-Daily Drinker
2.267400E-01
Normal-vs-Weekly Drinker
8.549800E-01
Normal-vs-Occasional Drinker
3.299800E-01
Normal-vs-Social Drinker
3.395600E-01
Non Drinker-vs-Daily Drinker
3.351600E-01
Non Drinker-vs-Weekly Drinker
2.583000E-01
Non Drinker-vs-Occasional Drinker
9.001200E-01
Non Drinker-vs-Social Drinker
7.140400E-01
Daily Drinker-vs-Weekly Drinker
1.021390E-01
Daily Drinker-vs-Occasional Drinker
3.421400E-01
Daily Drinker-vs-Social Drinker
5.878400E-01
Weekly Drinker-vs-Occasional Drinker
2.224000E-01
Weekly Drinker-vs-Social Drinker
1.827760E-01
Occasional Drinker-vs-Social Drinker
7.450200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.729200E-01
Normal-vs-Grade 2
7.698400E-01
Normal-vs-Grade 3
7.397200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.423200E-01
Grade 1-vs-Grade 3
4.530600E-01
Grade 1-vs-Grade 4
7.729200E-01
Grade 2-vs-Grade 3
2.860600E-01
Grade 2-vs-Grade 4
7.698400E-01
Grade 3-vs-Grade 4
7.397200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.156600E-01
Normal-vs-NonDiabetic
5.443200E-01
Diabetic-vs-NonDiabetic
9.502200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.685010E-01
Normal-vs-NoPancreatitis
5.954800E-01
Pancreatitis-vs-NoPancreatitis
2.914800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.444400E-01
Normal-vs-N1
6.404600E-01
N0-vs-N1
6.826400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.558600E-01
Normal-vs-TP53-NonMutant
7.456400E-01
TP53-Mutant-vs-TP53-NonMutant
6.869800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
